6451-86-1 Usage
Description
2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde is an organic compound that serves as an intermediate in the synthesis of various pharmaceutical and cosmetic agents. It is characterized by the presence of a bromo, methoxy, and benzyloxy group attached to a benzene ring, which contributes to its unique chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde is used as an intermediate in the synthesis of 3,8-Dihydroxy-9-methoxy-6H-Dibenzo[b,d]pyran-6-one (D455545), a compound with potential applications in anti-wrinkle agents. It is known to promote collagen production, inhibit MMP-1 production, and reduce elastase activity, making it a valuable component in the development of anti-aging treatments.
Used in Cosmetic Industry:
In the cosmetic industry, 2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde is used as a key component in the formulation of anti-aging products. Its role in promoting collagen production and inhibiting enzymes that degrade skin elasticity contributes to the development of effective anti-wrinkle agents, helping to maintain youthful and healthy skin appearance.
Check Digit Verification of cas no
The CAS Registry Mumber 6451-86-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,4,5 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6451-86:
(6*6)+(5*4)+(4*5)+(3*1)+(2*8)+(1*6)=101
101 % 10 = 1
So 6451-86-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H13BrO3/c1-18-14-8-13(16)12(9-17)7-15(14)19-10-11-5-3-2-4-6-11/h2-9H,10H2,1H3
6451-86-1Relevant articles and documents
On the chloride lability in electron-rich second-generation ruthenium benzylidene complexes
Strasser, Simone,Pump, Eva,Fischer, Roland C.,Slugovc, Christian
, p. 1143 - 1151 (2015)
A series of electron-rich second-generation cis-dichloro ruthenium aldehyde-chelating benzylidene complexes was prepared, characterized, and tested in typical ring-opening metathesis polymerization (ROMP) experiments. The benzylidene precursors were prepa
DIMERIC COMPOUNDS AS STING AGONISTS
-
Paragraph 553, (2021/06/11)
The present disclosure relates to dimeric STING agonists of Formulae (I), (II), (III), (IV), (V), and (VI), and pharmaceutically acceptable salts thereof. The present disclosure also relates to methods of preparing the compounds and methods of using the c
Fused tricyclic compounds and application thereof in medicaments
-
Paragraph 0377-0381, (2020/03/17)
The invention relates to fused tricyclic compounds and an application thereof in medicaments, and in particular to an application of the fused tricyclic compounds in medicaments for treating and/or preventing hepatitis B. In particular, the invention rela
